Abstract
Introduction Less adherence to antiretroviral treatment (ART) has been found among people suffering from HIV (PWH) with comorbid mental disorders like depression and alcohol use in Mozambique, a Sub-Saharan African country. However, less is explored with regards to other mental disorders.
Methods This study assessed the association of multiple mental disorders and adherence to ART based on the data from primary/tertiary health care facilities in Maputo and Nampula, Mozambique. We administered a sociodemographic questionnaire, Mini International Neuropsychiatric Interview (MINI) Plus 4.0.0 adapted for use in Mozambique to assess mental conditions, and a 3-item self-report to measure ART adherence.
Results Out of 1469 participants, 409 were HIV positive (self-report), with an average age of 36.7 years (SD=9.8), and 30.4% were male. The most common mental disorders were major depressive disorder (27.34%) followed by psychosis (22.03%), suicidal ideation/behavior (15.44%), and alcohol-use disorder (8.35%). Higher levels of non-adherence to ART [(Mean Difference=1.19, 95% CI: 1.04, 1.37)] and the likelihood of missing at least one dose in the last 30 days (OR=3.06, 95% CI: 2.00, 4.67) were found in participants with any mental disorder compared to those without a mental disorder. The highest levels of non-adherence were observed among those with drug use disorders and panic disorder.
Conclusions In Mozambique, PWH with any co-occurring mental conditions had a lower probability of ART adherence. Integrating comprehensive mental health assessment and treatment and ART adherence interventions tailored to PWH with co-occurring mental disorders is necessary to attain optimal ART adherence and reach the UNAIDS ART target.
Competing Interest Statement
Dr. Oquendo receives royalties from the Research Foundation for Mental Hygiene for the Columbia Suicide Severity Rating Scale's commercial use and owns shares in Mantra, Inc. She serves as an advisor to Alkermes and Fundacion Jimenez Diaz (Madrid). Her family owns stock in Bristol Myers Squibb. The other authors declare no competing interests.
Funding Statement
This study was supported by NIMH grant U19MH113203 and T32MH096724; and Fogarty International Center grant D43TW009675.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the New York State Psychiatric Institute Institutional Review Board (#7479) and the Ethics Council of Eduardo Mondlane University (CIBS FM & HCM/54/2017).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Senior co-authors
E-mail addresses of authors: Flavio M. Mandlate:fmachado14{at}gmail.com
M. Claire Greene: mg4069{at}cumc.columbia.edu
Luis F. Pereira: lg2987{at}cumc.columbia.edu
Maria Lidia Gouveia: vovotetchauque{at}gmail.com
Jair Jesus Mari: jamari17{at}gmail.com
Francine Cournos: fc15{at}cumc.columbia.edu
Cristiane S Duarte: Cristiane.Duarte{at}nyspi.columbia.edu
Maria A. Oquendo: moquendo{at}pennmedicine.upenn.edu
Milton Wainberg: Milton.Wainberg{at}nyspi.columbia.edu
Marcelo Feijó Mello: feijomellom{at}me.com
Data Availability
All data produced in the present work are contained in the manuscript
List of abbreviations
- ACTG
- Adult AIDS Clinical Trials Group adherence questionnaire
- AIDS
- Acquired Immunodeficiency Syndrome
- ART
- Antiretroviral Treatment
- ARV
- Antiretroviral
- AUD
- Alcohol Disorder
- AUDIT
- Alcohol Use Disorder Tool
- ART
- Highly Active Antiretroviral Therapy
- EDM
- electronic drug monitor
- HIV/AIDS
- Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome
- MDD
- Major Depressive Disorder
- MD
- Mental Disorder
- MH
- Mental Health
- MINI
- Plus Mini-International Neuropsychiatric Interview Plus 4.0.0
- PWH
- People Living With Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome sSA – Sub-Saharan Africa
